My research is about the role of senescence in bioartificial liver design with a focus on optimizing functional bioartificial liver device to replace the metabolic activities of the liver as a bridge to transplant or organ recovery after liver decompensation. I am interested in better understanding of the role of senescence with the progression of liver disease and success of BAL design may lead to a better therapeutic option for the growing population of patient-facing liver failure into the future. I am also interested in considering routes to mitigate the effect of senescence in BAL organ design through the protective effect of antioxidants and RNA splicing reverse compounds.